Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002293 · ClinicalTrials.gov registry record · NA
A Study of Nystatin in the Prevention of Fungal Infections of the Mouth in Patients With AIDS or AIDS-Related Syndromes
A NA study, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- NA
- Development phase
NCT00002293: Completed NA study, sponsored by Bristol-Myers Squibb.
NCT00002293 is a NA study that has completed, run by Bristol-Myers Squibb. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002293, a NA study, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To determine a safe, effective, and convenient dosing schedule for nystatin pastilles in the prophylaxis of oral candidiasis in patients with AIDS or AIDS related syndromes (group III or IV, CDC classification)
Interventions
- DRUG Nystatin
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
What the finished NCT00002293 record still lists
NCT00002293 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Nystatin is the first listed.
NCT00002293 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002293 about?
NCT00002293 is a clinical study titled "A Study of Nystatin in the Prevention of Fungal Infections of the Mouth in Patients With AIDS or AIDS-Related Syndromes". To determine a safe, effective, and convenient dosing schedule for nystatin pastilles in the prophylaxis of oral candidiasis in patients with AIDS or AIDS related syndromes (group III or IV, CDC classification)
What is the current status of trial NCT00002293?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002293?
The interventions under investigation include: Nystatin (DRUG).
Who is sponsoring clinical trial NCT00002293?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.